Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Early research (Phase 1)Not Yet RecruitingNCT07334574
What this trial is testing

Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL

Who this might be right for
B-cell Non-Hodgkin's Lymphoma (B-NHL)
Ruijin Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Early research (Phase 1)Temporarily pausedNCT04746131
What this trial is testing

Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
B-cell Non-Hodgkin's Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT05338931
What this trial is testing

Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin Lymphoma
AbClon 82
Early research (Phase 1)Looking for participantsNCT07052305
What this trial is testing

NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Washington University School of Medicine 24
Very early researchUnknownNCT05444322
What this trial is testing

RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Who this might be right for
Mantle Cell LymphomaDiffuse Large B-cell LymphomaFollicular Lymphoma
He Huang 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05222555
What this trial is testing

Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
Incyte Corporation 53
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 42
Not applicableNot Yet RecruitingNCT06879470
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Lymphoma

Who this might be right for
B-Non Hodgkin Lymphoma
He Huang 24
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Early research (Phase 1)Study completedNCT02220842
What this trial is testing

A Safety and Pharmacology Study of Atezolizumab (MPDL3280A) Administered With Obinutuzumab or Tazemetostat in Participants With Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Study completedNCT03589469
What this trial is testing

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
ADC Therapeutics S.A. 145
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07601607
What this trial is testing

Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Sun Yat-sen University 51
Early research (Phase 1)Active Not RecruitingNCT05206357
What this trial is testing

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Who this might be right for
Non-hodgkin Lymphoma
Genmab 17
Early research (Phase 1)Active Not RecruitingNCT04970901
What this trial is testing

Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

Who this might be right for
B-Cell Non-Hodgkin LymphomaRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma
ADC Therapeutics S.A. 154
Early research (Phase 1)Study completedNCT01722305
What this trial is testing

Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma

Who this might be right for
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaCentral Nervous System LymphomaIntraocular Lymphoma+3 more
Mayo Clinic 29
Testing effectiveness (Phase 2)UnknownNCT01799083
What this trial is testing

Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas

Who this might be right for
Solid TumorsB Cell Lymphoma
Han weidong 100
Next Page